Renal and Neurologic Benefit of Levosimendan vs Dobutamine in Patients With Low Cardiac Output Syndrome After Cardiac Surgery: Clinical Trial FIM-BGC-2014-01

BACKGROUND: Low-cardiac output syndrome (LCOS) after cardiac surgery secondary to systemic hypoperfusion is associated with a higher incidence of renal and neurological damage. A range of effective therapies are available for LCOS. The beneficial systemic effects of levosimendan persist even after c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Guerrero-Orriach, Jose L., Malo-Manso, Alfredo, Ramirez-Aliaga, Marta, Florez Vela, Ana Isabel, Galán-Ortega, Manuel, Moreno-Cortes, Isabel, Gonzalez-Almendros, Inmaculada, Ramirez-Fernandez, Alicia, Ariza-Villanueva, Daniel, Escalona-Belmonte, Juan Jose, Quesada-Muñoz, Guillermo, Sepúlveda-Haro, Enrique, Romero-Molina, Salvador, Bellido-Estevez, Inmaculada, Gomez-Luque, Aurelio, Rubio-Navarro, Manuel, Alcaide-Torres, Juan, Santiago-Fernandez, Concepcion, Garrido-Sanchez, Lourdes, Cruz-Mañas, Jose
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7479222/
https://ncbi.nlm.nih.gov/pubmed/32982742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.01331
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados